Skip to content

Influence of Dietary Fiber-rich Meals on Gene Expression and Postprandial Glucose and Lipid Response

The Influence of Dietary Fibre-rich Meals on Gene Expression in Leukocytes and Postprandial Glucose and Lipid Response in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01005342
Enrollment
18
Registered
2009-10-30
Start date
2007-05-31
Completion date
2007-06-30
Last updated
2009-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoglycemia, Hyperglycemia

Keywords

gene expression, oats, rye, sugar beet fiber, glucose, insulin, triglyceride, decreased postprandial glucose, decreased postprandial insulin, glycemic index

Brief summary

The aim of this study is to * Measure the effect on gene expression in leukocytes from a meal rich in oat bran * Investigate the postprandial glucose, insulin and triglyceride responses after intake of meals containing fiber from different sources (oat, rye and sugar beet fiber) or a meal containing a mixture of these three fibers

Detailed description

Dietary fiber has long been known to give beneficial health effects. Yet, the understanding of how fiber-rich meals regulate molecular events at a gene level is limited. Also, few studies have compared the effects of different fiber sources on postprandial responses and hardly any study the effects of fiber mixtures in the same meal, even though this is more similar to regular eating habits. Healthy subjects will come to the study center after an overnight fast, to ingest breakfasts randomly enriched with different fiber. The meals contains either spray-dried oat drink, rye bran, sugar beet fiber a mixture of these three fibers, oat bran or no added fiber (control). All meals are adjusted to contain the same total amount of available carbohydrates and fat. Blood leukocytes for gene expression profiling were taken before and 2 h after consumption while blood samples for analysis of postprandial glucose, insulin and triglyceride levels were taken every 30 min during 3 h. NuGO Affymetrix Human Genechip NuGO\_Hs1a520180 are used for the microarray analysis and analysis is performed with linear mixed models and enrichment analysis to identify functional gene sets that responded to the specific oat bran effect.

Interventions

82 g oat bran was added to 250 ml blackcurrant beverage with pulp to give 5 g soluble fiber (12.6 g total fiber).

OTHERSpray-dried oat drink

62 g spray-dried oat drink was added to 250 ml blackcurrant beverage with pulp to give 2.7 g soluble fiber (3.3 g total fiber).

OTHERRye bran

31 g rye bran was added to 250 ml blackcurrant beverage with pulp to give 1.7 g soluble fiber (12 g total fiber).

OTHERSugar beet fiber

19 g sugar beet fiber was added to 250 ml blackcurrant beverage with pulp to give 5 g soluble fiber (12 g total fiber).

OTHERMixture of fiber

38 g spray-dried oat drink, 30 g rye bran and 6 g sugar beet fiber were added to 250 ml blackcurrant beverage with pulp to give 5 g soluble fiber (18 g total fiber).

OTHERControl

No fiber was added to control meal (250 g black-currant beverage)

Sponsors

Vinnova
CollaboratorOTHER_GOV
Oatly AB
CollaboratorUNKNOWN
Lantmannen Food R&D
CollaboratorUNKNOWN
Danisco Sugar AB/Fibrex
CollaboratorUNKNOWN
Lund University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 18-30

Exclusion criteria

* pregnancy * breastfeeding * diabetes mellitus * hepatitis B * blood lipid lowering pharmaceuticals * intolerance or allergy to cereals or sugar beet fiber

Design outcomes

Primary

MeasureTime frame
Changed gene expression profile by fiber-rich meals2 h after meal intake

Secondary

MeasureTime frame
Lowering of postprandial glucose by fiber-rich meals0-180 min after meal intake

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026